US › Healthcare

Precipio Inc (PRPO)

US · Healthcare · Diagnostics & Research

$22.75+2.80%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$6.3M
Revenue YoY
+48.0%
Net profit
$-1.4M
Profit YoY
-63.2%
EPS
$-0.81
Net margin
-22.9%

Key statistics

Market cap
$38.7M
Forward P/E
15.4
P/B
2.73
Book value
$7.94
EPS (TTM)
$-0.45
52-week high
$33.63
52-week low
$13.80
50-day MA
$23.50
200-day MA
$24.35
Beta
1.29

Analyst view

Analysts rate Precipio Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $19.00.

Shareholding

Insiders
12.65%
Institutions
17.69%

Largest institutional holders

FundStake
BlackRock Inc1.62%
Vanguard Capital Management, LLC1.43%
Topline Capital Management LLC1.38%
Renaissance Technologies Corp1.08%
Geode Capital Management, LLC1.05%
Citadel Advisors Llc0.85%
Evernest Financial Advisors LLC0.53%
Vanguard Fiduciary Trust Co0.52%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Precipio Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.